Important OptumRx updates to support providers, clinical staff and patients through COVID-19.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 15, 2019 - The FDA announced the discontinuation of Ironwood Pharmaceuticals’ Duzallo (lesinurad/allopurinol) and Zurampic (lesinurad).
Download PDF
Return to publications
